<ul><li>Remidio Innovative Solutions has obtained CDSCO approval for its AI-based tools to detect glaucoma and AMD, following the success of their diabetic retinopathy tool.</li><li>The new glaucoma and AMD tools are designed to work offline, making them suitable for use in remote areas with limited access to eye care specialists.</li><li>Medios HI Glaucoma AI detects early signs of glaucoma using heat maps, addressing the issue of underdiagnosis in India where over 90% of glaucoma cases remain undetected.</li><li>The AI tools have been tested in real hospitals and integrated into Remidio's portable eye camera device, enabling quick and accurate detection of glaucoma, AMD, and diabetic retinopathy.</li></ul>

Remidio’s AI Tools for Glaucoma, AMD Get CDSCO Approval

Discover more